According to a study published in Liver Transplantation, liver transplant recipients who continue to smoke or have smoked in the past are more likely to acquire viral hepatitis reinfection after the procedure. Each year, more than 5 million people in t…

( Wiley ) Transplant recipients who smoke or have smoked increase their risk of viral hepatitis reinfection following liver transplantation according to new research available in the July issue of Liver Transplantation, a journal published by Wiley on …

An existing drug dramatically reduced the most serious complications of bone marrow transplants, University of Pennsylvania researchers are reporting Thursday.

( University of Pennsylvania School of Medicine ) An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research…

An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research from the Perelman School of Medicine at the Unive…

PHILADELPHIA — An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research from the Perelman School of Medi…

WASHINGTON, July 11 (UPI) — A U.S. government agency is pushing its polygraph operators to obtain intimate information of thousands of job applicants, a newspaper investigation said.

It was supposed to be a life-changing organ transplant. But the pancreas given to patient Rashia Wimley at the University of Chicago Medical Center in the summer of 2008 was cancerous, a lawsuit filed Monday alleges. Now Wimley, 39, says she’s been d…

Washington, July 9 (ANI): Researchers have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant from an unrelated donor.

Researchers have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant from an unrelated donor.